Is Monogram Orthopaedics Stock a Good Investment?
Monogram Orthopaedics Investment Advice | MGRM |
- Examine Monogram Orthopaedics' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Monogram Orthopaedics' leadership team and their track record. Good management can help Monogram Orthopaedics navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact Monogram Orthopaedics' business and its evolving consumer preferences.
- Compare Monogram Orthopaedics' performance and market position to its competitors. Analyze how Monogram Orthopaedics is positioned in terms of product offerings, innovation, and market share.
- Check if Monogram Orthopaedics pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Monogram Orthopaedics' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Monogram Orthopaedics Common stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Monogram Orthopaedics Common is a good investment.
Sell | Buy |
Sell
Market Performance | Very Weak | Details | |
Volatility | Unstable | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Average | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
Examine Monogram Orthopaedics Stock
Researching Monogram Orthopaedics' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 34.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.5. Monogram Orthopaedics had not issued any dividends in recent years.
To determine if Monogram Orthopaedics is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Monogram Orthopaedics' research are outlined below:
| Monogram Orthopaedics had very high historical volatility over the last 90 days | |
| Monogram Orthopaedics has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (16.33 M) with profit before overhead, payroll, taxes, and interest of 365 K. | |
| Monogram Orthopaedics generates negative cash flow from operations | |
| Monogram Orthopaedics has a poor financial position based on the latest SEC disclosures | |
| About 34.0% of the company outstanding shares are owned by corporate insiders |
Monogram Orthopaedics Quarterly Cash And Short Term Investments |
|
Monogram Orthopaedics uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Monogram Orthopaedics Common. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Monogram Orthopaedics' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 14th of February 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Earnings surprises can significantly impact Monogram Orthopaedics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Monogram Orthopaedics' investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2025-05-15 | 2025-03-31 | -0.115 | -0.1 | 0.015 | 13 | ||
2024-08-15 | 2024-06-30 | -0.09 | -0.11 | -0.02 | 22 | ||
2025-03-13 | 2024-12-31 | -0.11 | -0.08 | 0.03 | 27 | ||
2024-11-20 | 2024-09-30 | -0.12 | -0.16 | -0.04 | 33 |
Monogram Orthopaedics' market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 100.28 M.Market Cap |
|
Monogram Orthopaedics' profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.94) | (0.98) | |
| Return On Capital Employed | (0.94) | (0.90) | |
| Return On Assets | (0.92) | (0.96) | |
| Return On Equity | (1.13) | (1.07) |
Determining Monogram Orthopaedics' profitability involves analyzing its financial statements and using various financial metrics to determine if Monogram Orthopaedics is a good buy. For example, gross profit margin measures Monogram Orthopaedics' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Monogram Orthopaedics' profitability and make more informed investment decisions.
Evaluate Monogram Orthopaedics' management efficiency
Monogram Orthopaedics has return on total asset (ROA) of (0.6736) % which means that it has lost $0.6736 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.4609) %, meaning that it created substantial loss on money invested by shareholders. Monogram Orthopaedics' management efficiency ratios could be used to measure how well Monogram Orthopaedics manages its routine affairs as well as how well it operates its assets and liabilities. As of the 25th of June 2025, Return On Tangible Assets is likely to drop to -0.98. In addition to that, Return On Capital Employed is likely to grow to -0.9. At this time, Monogram Orthopaedics' Total Current Assets are very stable compared to the past year. As of the 25th of June 2025, Non Currrent Assets Other is likely to grow to about 850.5 K, while Non Current Assets Total are likely to drop about 1.4 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.45 | 0.47 | |
| Tangible Book Value Per Share | 0.43 | 0.46 | |
| Enterprise Value Over EBITDA | (3.89) | (4.09) | |
| Price Book Value Ratio | 5.32 | 5.59 | |
| Enterprise Value Multiple | (3.89) | (4.09) | |
| Price Fair Value | 5.32 | 5.59 | |
| Enterprise Value | 61.9 M | 58.8 M |
The strategic initiatives led by Monogram Orthopaedics' management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.
Beta 0.409 |
Basic technical analysis of Monogram Stock
As of the 25th of June, Monogram Orthopaedics secures the Mean Deviation of 2.96, standard deviation of 3.87, and Risk Adjusted Performance of (0.01). In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Monogram Orthopaedics, as well as the relationship between them. Please verify Monogram Orthopaedics information ratio and skewness to decide if Monogram Orthopaedics Common is priced some-what accurately, providing market reflects its recent price of 2.87 per share. Please also check out Monogram Orthopaedics jensen alpha, which is currently at (0.08) to check the company can sustain itself at a future point.Monogram Orthopaedics' insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Monogram Orthopaedics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Monogram Orthopaedics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Monogram Orthopaedics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Welch William J over three months ago Acquisition by Welch William J of 100000 shares of Monogram Orthopaedics at 1.88 subject to Rule 16b-3 | ||
Knape Noel over six months ago Acquisition by Knape Noel of 288461 shares of Monogram Orthopaedics at 2.08 subject to Rule 16b-3 | ||
Merriweather Alfred G over six months ago Acquisition by Merriweather Alfred G of 100000 shares of Monogram Orthopaedics at 1.88 subject to Rule 16b-3 | ||
Mendlein John over six months ago Acquisition by Mendlein John of 20000 shares of Monogram Orthopaedics at 1.88 subject to Rule 16b-3 | ||
Knape Noel over a year ago Acquisition by Knape Noel of 25000 shares of Monogram Orthopaedics at 2.33 subject to Rule 16b-3 | ||
Goddard Noel over a year ago Monogram Orthopaedics exotic insider transaction detected |
Monogram Orthopaedics' Outstanding Corporate Bonds
Monogram Orthopaedics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Monogram Orthopaedics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Monogram bonds can be classified according to their maturity, which is the date when Monogram Orthopaedics Common has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Understand Monogram Orthopaedics' technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Monogram Orthopaedics' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | (0.06) | |||
| Mean Deviation | 2.96 | |||
| Coefficient Of Variation | (10,551) | |||
| Standard Deviation | 3.87 | |||
| Variance | 14.96 | |||
| Information Ratio | (0.02) | |||
| Jensen Alpha | (0.08) | |||
| Total Risk Alpha | (0.15) | |||
| Treynor Ratio | (0.07) | |||
| Maximum Drawdown | 15.23 | |||
| Value At Risk | (6.43) | |||
| Potential Upside | 5.93 | |||
| Skewness | (0.14) | |||
| Kurtosis | 0.2102 |
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | (0.06) | |||
| Mean Deviation | 2.96 | |||
| Coefficient Of Variation | (10,551) | |||
| Standard Deviation | 3.87 | |||
| Variance | 14.96 | |||
| Information Ratio | (0.02) | |||
| Jensen Alpha | (0.08) | |||
| Total Risk Alpha | (0.15) | |||
| Treynor Ratio | (0.07) | |||
| Maximum Drawdown | 15.23 | |||
| Value At Risk | (6.43) | |||
| Potential Upside | 5.93 | |||
| Skewness | (0.14) | |||
| Kurtosis | 0.2102 |
Consider Monogram Orthopaedics' intraday indicators
Monogram Orthopaedics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Monogram Orthopaedics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Monogram Orthopaedics Corporate Filings
10Q | 14th of May 2025 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
8K | 29th of April 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 16th of April 2025 Other Reports | ViewVerify | |
8K | 13th of March 2025 An amendment to a previously filed Form 8-K | ViewVerify |
Monogram Stock media impact
There is far too much social signal, news, headlines, and media speculation about Monogram Orthopaedics that are available to investors today. This information is accessible both publicly - through Monogram Orthopaedics' media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Monogram-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Monogram Orthopaedics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Monogram Orthopaedics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Monogram Orthopaedics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Monogram Orthopaedics alpha.
Monogram Orthopaedics Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Monogram Orthopaedics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Monogram Orthopaedics Corporate Executives
Elected by the shareholders, the Monogram Orthopaedics' board of directors comprises two types of representatives: Monogram Orthopaedics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Monogram. The board's role is to monitor Monogram Orthopaedics' management team and ensure that shareholders' interests are well served. Monogram Orthopaedics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Monogram Orthopaedics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Douglas Unis | Chief Founder | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Monogram Orthopaedics Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Monogram Orthopaedics. If investors know Monogram will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Monogram Orthopaedics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Monogram Orthopaedics is measured differently than its book value, which is the value of Monogram that is recorded on the company's balance sheet. Investors also form their own opinion of Monogram Orthopaedics' value that differs from its market value or its book value, called intrinsic value, which is Monogram Orthopaedics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Monogram Orthopaedics' market value can be influenced by many factors that don't directly affect Monogram Orthopaedics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Monogram Orthopaedics' value and its price, as these two are different measures arrived at by various means. Investors typically determine if Monogram Orthopaedics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Monogram Orthopaedics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.